Airway eosinophilic inflammation indicates small airway dysfunction (SAD) in patients with mild stable or at risk for COPD – results from CAPTO-COPD

M. Abdo (Grosshansdorf, Germany), F. Pedersen (Grosshansdorf, Germany), F. Trinkmann (Heidelberg, Germany), F. Herth (Heidelberg, Germany), K. Rabe (Grosshansdorf, Germany), A. Kirsten (Grosshansdorf, Germany), H. Watz (Grosshansdorf, Germany)

Source: International Congress 2022 – Emerging therapeutic targets, biomarkers and mechanisms of chronic lung disease
Session: Emerging therapeutic targets, biomarkers and mechanisms of chronic lung disease
Session type: Thematic Poster
Number: 3573

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Abdo (Grosshansdorf, Germany), F. Pedersen (Grosshansdorf, Germany), F. Trinkmann (Heidelberg, Germany), F. Herth (Heidelberg, Germany), K. Rabe (Grosshansdorf, Germany), A. Kirsten (Grosshansdorf, Germany), H. Watz (Grosshansdorf, Germany). Airway eosinophilic inflammation indicates small airway dysfunction (SAD) in patients with mild stable or at risk for COPD – results from CAPTO-COPD. 3573

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.